Theravance Biopharma, Inc. (TBPH)
17.01
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
16.98
-0.03
(-0.18%)
After-Hours: 07:22
Theravance Biopharma Profit Margin (Quarterly) : -28.45% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.45% |
| March 31, 2026 | -27.87% |
| December 31, 2025 | |
| September 30, 2025 | 18.08% |
| June 30, 2025 | |
| March 31, 2025 | -88.24% |
| December 31, 2024 | -82.80% |
| September 30, 2024 | -75.28% |
| June 30, 2024 | -115.9% |
| March 31, 2024 | -80.42% |
| December 31, 2023 | -48.45% |
| September 30, 2023 | -57.03% |
| June 30, 2023 | -113.8% |
| March 31, 2023 | -212.0% |
| December 31, 2022 | -97.33% |
| September 30, 2022 | -128.7% |
| June 30, 2022 | -206.3% |
| March 31, 2022 | -305.1% |
| December 31, 2021 | -386.9% |
| September 30, 2021 | -423.8% |
| June 30, 2021 | -405.8% |
| March 31, 2021 | -558.9% |
| December 31, 2020 | -312.0% |
| September 30, 2020 | -403.4% |
| June 30, 2020 | -419.0% |
| Date | Value |
|---|---|
| March 31, 2020 | -418.2% |
| December 31, 2019 | -222.4% |
| September 30, 2019 | -470.2% |
| June 30, 2019 | -152.3% |
| March 31, 2019 | -1.36K% |
| December 31, 2018 | -318.9% |
| September 30, 2018 | -462.9% |
| June 30, 2018 | -173.9% |
| March 31, 2018 | -782.4% |
| December 31, 2017 | -1.93K% |
| September 30, 2017 | -1.56K% |
| June 30, 2017 | -1.89K% |
| March 31, 2017 | -2.12K% |
| December 31, 2016 | -1.18K% |
| September 30, 2016 | -178.0% |
| June 30, 2016 | -863.2% |
| March 31, 2016 | -229.0% |
| December 31, 2015 | -1.15K% |
| September 30, 2015 | -442.3% |
| June 30, 2015 | -667.3% |
| March 31, 2015 | -208.2% |
| December 31, 2014 | -4.49K% |
| September 30, 2014 | -860.1% |
| June 30, 2014 | -1.96K% |
| March 31, 2014 | -6.35K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Zymeworks, Inc. | -980.8% |
| Viatris, Inc. | -3.16% |
| Ocular Therapeutix, Inc. | -584.5% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.16% |
| Return on Assets | 11.86% |
| Return on Invested Capital | 16.35% |
| Gross Profit Margin (Quarterly) | 93.04% |
| Operating Margin (Quarterly) | -2.91% |
| Return on Net Operating Assets | 83.44% |